{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=FLOVENT+100mcg&page=2", "query": { "intervention": "FLOVENT 100mcg", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=FLOVENT+100mcg&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-09-28T14:26:09.832Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00927758", "title": "Pilot Study to Examine the Post-Dose Changes in Exhaled Nitric Oxide (eNO) Following Treatment With Fluticasone Propionate (FP)/Salmeterol (SAL) Combination Product Advair", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "fluticasone propionate/salmeterol (Flu/Sal) : 100mcg/50mcg, 250mcg/50mcg,500mcg/50 mcg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sandoz", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 105, "start_date": "2009-06", "completion_date": "2009-12", "has_results": true, "last_update_posted_date": "2017-03-29", "last_synced_at": "2026-09-28T14:26:09.832Z", "location_count": 3, "location_summary": "Gainesville, Florida • Iowa City, Iowa • Madison, Wisconsin", "locations": [ { "city": "Gainesville", "state": "Florida" }, { "city": "Iowa City", "state": "Iowa" }, { "city": "Madison", "state": "Wisconsin" } ], "official_url": "https://clinicaltrials.gov/study/NCT00927758" }, { "nct_id": "NCT01475721", "title": "SAS115359: A 6-month Study to Assess the Safety and Benefit of Inhaled Fluticasone Propionate/Salmeterol Combination Compared With Inhaled Fluticasone Propionate in the Treatment of Adolescents and Adults (12 Years of Age and Older) With Asthma.", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "ADVAIR 100/50mcg", "type": "DRUG" }, { "name": "ADVAIR 250/50mcg", "type": "DRUG" }, { "name": "ADVAIR 500/50mcg", "type": "DRUG" }, { "name": "FLOVENT 100mcg", "type": "DRUG" }, { "name": "FLOVENT 250mcg", "type": "DRUG" }, { "name": "FLOVENT 500mcg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 11751, "start_date": "2011-11-18", "completion_date": "2015-06-23", "has_results": true, "last_update_posted_date": "2018-08-06", "last_synced_at": "2026-09-28T14:26:09.832Z", "location_count": 350, "location_summary": "Athens, Alabama • Birmingham, Alabama • Florence, Alabama + 273 more", "locations": [ { "city": "Athens", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Florence", "state": "Alabama" } ], "official_url": "https://clinicaltrials.gov/study/NCT01475721" }, { "nct_id": "NCT00116818", "title": "A Study of GW685698X for the Treatment Of Perennial Allergic Rhinitis in Adolescents and Adults", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Rhinitis, Allergic, Perennial" ], "interventions": [ { "name": "GW685698X aqueous nasal spray", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "12 Years to 65 Years" }, "enrollment_count": 90, "start_date": "2005-01", "completion_date": "2005-05", "has_results": false, "last_update_posted_date": "2016-09-15", "last_synced_at": "2026-09-28T14:26:09.832Z", "location_count": 1, "location_summary": "San Antonio, Texas", "locations": [ { "city": "San Antonio", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00116818" }, { "nct_id": "NCT01957163", "title": "Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Pulmonary Disease, Chronic Obstructive" ], "interventions": [ { "name": "FF", "type": "DRUG" }, { "name": "VI", "type": "DRUG" }, { "name": "UMEC", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 619, "start_date": "2013-10-01", "completion_date": "2014-04-01", "has_results": true, "last_update_posted_date": "2017-11-09", "last_synced_at": "2026-09-28T14:26:09.832Z", "location_count": 13, "location_summary": "Jasper, Alabama • Clearwater, Florida • Tampa, Florida + 10 more", "locations": [ { "city": "Jasper", "state": "Alabama" }, { "city": "Clearwater", "state": "Florida" }, { "city": "Tampa", "state": "Florida" }, { "city": "New Orleans", "state": "Louisiana" }, { "city": "St Louis", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT01957163" }, { "nct_id": "NCT01436110", "title": "Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate and Fluticasone Propionate in People With Asthma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Fluticasone furoate 50mcg", "type": "DRUG" }, { "name": "Fluticasone propionate 100mcg", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 351, "start_date": "2011-09", "completion_date": "2012-09", "has_results": true, "last_update_posted_date": "2017-01-09", "last_synced_at": "2026-09-28T14:26:09.832Z", "location_count": 20, "location_summary": "Los Angeles, California • Rolling Hills Estates, California • Sacramento, California + 17 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Rolling Hills Estates", "state": "California" }, { "city": "Sacramento", "state": "California" }, { "city": "San Jose", "state": "California" }, { "city": "Aventura", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01436110" }, { "nct_id": "NCT00920543", "title": "GSK BHR Study (Sont)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "FP 100mcg", "type": "DRUG" }, { "name": "FP 500mcg", "type": "DRUG" }, { "name": "FP 250mcg", "type": "DRUG" }, { "name": "FSC 100/50mcg", "type": "DRUG" }, { "name": "FSC 250/50mcg", "type": "DRUG" }, { "name": "FSC 500/50mcg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 464, "start_date": "2003-02", "completion_date": "2004-10", "has_results": false, "last_update_posted_date": "2016-09-01", "last_synced_at": "2026-09-28T14:26:09.832Z", "location_count": 52, "location_summary": "Birmingham, Alabama • Phoenix, Arizona • Tucson, Arizona + 45 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Carmichael", "state": "California" }, { "city": "Palmdale", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00920543" }, { "nct_id": "NCT02119286", "title": "Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) -Study 2", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Pulmonary Disease, Chronic Obstructive" ], "interventions": [ { "name": "FF", "type": "DRUG" }, { "name": "VI", "type": "DRUG" }, { "name": "UMEC", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 620, "start_date": "2013-10", "completion_date": "2014-04", "has_results": true, "last_update_posted_date": "2017-03-23", "last_synced_at": "2026-09-28T14:26:09.832Z", "location_count": 14, "location_summary": "Mobile, Alabama • Phoenix, Arizona • Huntington Beach, California + 11 more", "locations": [ { "city": "Mobile", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Huntington Beach", "state": "California" }, { "city": "DeLand", "state": "Florida" }, { "city": "Orlando", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT02119286" }, { "nct_id": "NCT01323634", "title": "Study to Evaluate the 24-Hour Pulmonary Function Profile of Fluticasone Furoate (FF) /GW642444 (Vilanterol) (VI) Inhalation Powder 100/25mcg Once Daily Compared With Fluticasone Propionate/Salmeterol Inhalation Powder 250/50mcg Twice Daily in Subjects With Chronic Obstructive Pulmonary Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Pulmonary Disease, Chronic Obstructive" ], "interventions": [ { "name": "Fluticasone Furoate 100mcg / GW642444 (vilanterol) 25mcg", "type": "DRUG" }, { "name": "Fluticasone Propionate 250mcg/ salmeterol 50mcg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 519, "start_date": "2011-03-18", "completion_date": "2011-12-14", "has_results": true, "last_update_posted_date": "2017-11-08", "last_synced_at": "2026-09-28T14:26:09.832Z", "location_count": 12, "location_summary": "Los Angeles, California • Orlando, Florida • Atlanta, Georgia + 9 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Orlando", "state": "Florida" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Madisonville", "state": "Kentucky" }, { "city": "St Louis", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT01323634" }, { "nct_id": "NCT01520688", "title": "Effect of Flovent Discus vs QVAR vs Pulmicort Flexhaler on Short Term Growth", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Fluticasone, Budesonide, Beclomethasone", "type": "DRUG" }, { "name": "Fluticasone, Beclomethasone, Budesonide", "type": "DRUG" }, { "name": "Budesonide, Fluticasone, Beclomethasone", "type": "DRUG" }, { "name": "Budesonide, Beclomethasone, Fluticasone", "type": "DRUG" }, { "name": "Beclomethasone, Fluticasone, Budesonide", "type": "DRUG" }, { "name": "Beclomethasone, Budesonide, Fluticasone", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "West Penn Allegheny Health System", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "6 Years", "maximum_age": "11 Years", "sex": "ALL", "summary": "6 Years to 11 Years" }, "enrollment_count": 32, "start_date": "2012-02", "completion_date": "2016-02", "has_results": true, "last_update_posted_date": "2020-11-18", "last_synced_at": "2026-09-28T14:26:09.832Z", "location_count": 2, "location_summary": "Green Tree, Pennsylvania • Pittsburgh, Pennsylvania", "locations": [ { "city": "Green Tree", "state": "Pennsylvania" }, { "city": "Pittsburgh", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT01520688" }, { "nct_id": "NCT01453023", "title": "Inhaled Fluticasone Furoate/Vilanterol Safety and Tolerability, PK and PD Study", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Fluticasone Furoate", "type": "DRUG" }, { "name": "Fluticasone Furoate/Vilanterol", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "5 Years", "maximum_age": "11 Years", "sex": "ALL", "summary": "5 Years to 11 Years" }, "enrollment_count": 26, "start_date": "2011-10", "completion_date": "2012-06", "has_results": true, "last_update_posted_date": "2017-01-11", "last_synced_at": "2026-09-28T14:26:09.832Z", "location_count": 1, "location_summary": "Huntington Beach, California", "locations": [ { "city": "Huntington Beach", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01453023" } ] }